{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:08:23Z","timestamp":1767035303015,"version":"3.48.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Mounir Armanious Research Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11340-2","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:51:18Z","timestamp":1766987478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a lipid peroxidation-dependent ferroptosis RNA panel expression as a potential noninvasive biomarker in patients with nonalcoholic steatohepatitis-associated hepatocellular carcinoma"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8715-641X","authenticated-orcid":false,"given":"Amr A.","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1507-1058","authenticated-orcid":false,"given":"Asmaa I.","family":"Nabeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6949-3304","authenticated-orcid":false,"given":"Marwa G. A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4177-6441","authenticated-orcid":false,"given":"Ali","family":"El Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-3954","authenticated-orcid":false,"given":"Marwa","family":"Matboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"11340_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan DJH, Ng CH, Lin SY, Pan XH, Tay P, Lim WH et al (2022) Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol 23:521\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(22)00078-X","journal-title":"Lancet Oncol"},{"key":"11340_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79:1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"key":"11340_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S et al (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3","journal-title":"Nat Rev Dis Primers"},{"key":"11340_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD 2019 Hepatitis B Collaborators","year":"2022","unstructured":"GBD 2019 Hepatitis B Collaborators (2022) Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol 7:796\u2013829. https:\/\/doi.org\/10.1016\/S2468-1253(22)00124-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11340_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM (2023) Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 20:864\u2013884. https:\/\/doi.org\/10.1038\/s41571-023-00825-3","journal-title":"Nat Rev Clin Oncol"},{"key":"11340_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225458","volume":"15","author":"BM Motta","year":"2023","unstructured":"Motta BM, Masarone M, Torre P, Persico M (2023) From non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and prevention. Cancers (Basel) 15:5458. https:\/\/doi.org\/10.3390\/cancers15225458","journal-title":"Cancers (Basel)"},{"key":"11340_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","volume":"75","author":"R Pinyol","year":"2021","unstructured":"Pinyol R, Torrecilla S, Wang H, Montironi C, Piqu\u00e9-Gili M, Torres-Martin M et al (2021) Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 75:865\u2013878. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.049","journal-title":"J Hepatol"},{"key":"11340_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8543763","volume":"2018","author":"O Kutlu","year":"2018","unstructured":"Kutlu O, Kaleli HN, Ozer E (2018) Molecular pathogenesis of nonalcoholic steatohepatitis (NASH)-related hepatocellular carcinoma. Can J Gastroenterol Hepatol 2018:8543763. https:\/\/doi.org\/10.1155\/2018\/8543763","journal-title":"Can J Gastroenterol Hepatol"},{"key":"11340_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","volume":"7","author":"J Wu","year":"2021","unstructured":"Wu J, Wang Y, Jiang R, Xue R, Yin X, Wu M, Meng Q (2021) Ferroptosis in liver disease: new insights into disease mechanisms. Cell Death Discov 7:276. https:\/\/doi.org\/10.1038\/s41420-021-00660-4","journal-title":"Cell Death Discov"},{"key":"11340_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/HEP.0000000000000390","volume":"80","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R (2024) Ferroptosis in hepatocellular carcinoma: from bench to bedside. Hepatology 80:721\u2013739. https:\/\/doi.org\/10.1097\/HEP.0000000000000390","journal-title":"Hepatology"},{"key":"11340_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC, Karin M (2023) ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol 79:362\u2013377. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.016","journal-title":"J Hepatol"},{"key":"11340_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225844","volume":"13","author":"I Grgurevic","year":"2021","unstructured":"Grgurevic I, Bozin T, Mikus M, Kukla M, O\u2019Beirne J (2021) Hepatocellular carcinoma in non-alcoholic fatty liver disease: from epidemiology to diagnostic approach. Cancers (Basel) 13:5844. https:\/\/doi.org\/10.3390\/cancers13225844","journal-title":"Cancers (Basel)"},{"key":"11340_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010210","volume":"24","author":"EA Ahmed","year":"2022","unstructured":"Ahmed EA, El-Derany MO, Anwar AM, Saied EM, Magdeldin S (2022) Metabolomics and lipidomics screening reveal reprogrammed signaling pathways toward cancer development in non-alcoholic steatohepatitis. Int J Mol Sci 24:210. https:\/\/doi.org\/10.3390\/ijms24010210","journal-title":"Int J Mol Sci"},{"key":"11340_CR14","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.3748\/wjg.v28.i27.3410","volume":"28","author":"M Ueno","year":"2022","unstructured":"Ueno M, Takeda H, Takai A, Seno H (2022) Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: current evidence and future perspectives. World J Gastroenterol 28:3410\u20133421. https:\/\/doi.org\/10.3748\/wjg.v28.i27.3410","journal-title":"World J Gastroenterol"},{"key":"11340_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207\u2013210. https:\/\/doi.org\/10.1093\/nar\/30.1.207","journal-title":"Nucleic Acids Res"},{"key":"11340_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101626","volume":"66","author":"AJ Vesting","year":"2022","unstructured":"Vesting AJ, Jais A, Klemm P, Steuernagel L, Wienand P, Fog-Tonnesen M et al (2022) NIK\/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2\/STAT5 inhibition. Mol Metab 66:101626. https:\/\/doi.org\/10.1016\/j.molmet.2022.101626","journal-title":"Mol Metab"},{"key":"11340_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:90\u201397. https:\/\/doi.org\/10.1093\/nar\/gkw377","journal-title":"Nucleic Acids Res"},{"key":"11340_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"11340_CR19","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","volume":"158","author":"R Loomba","year":"2020","unstructured":"Loomba R, Lim JK, Patton H, El-Serag HB (2020) AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review. Gastroenterology 158:1822\u20131830. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.053","journal-title":"Gastroenterology"},{"key":"11340_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846\u2013854. https:\/\/doi.org\/10.1002\/hep.21496","journal-title":"Hepatology"},{"key":"11340_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"11340_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"11340_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"key":"11340_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M et al (2019) Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis 10:449. https:\/\/doi.org\/10.1038\/s41419-019-1678-y","journal-title":"Cell Death Dis"},{"key":"11340_CR25","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00432-018-2740-3","volume":"144","author":"J Nie","year":"2018","unstructured":"Nie J, Lin B, Zhou M, Wu L, Zheng T (2018) Role of ferroptosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 144:2329\u20132337. https:\/\/doi.org\/10.1007\/s00432-018-2740-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"11340_CR26","doi-asserted-by":"publisher","first-page":"103661","DOI":"10.1016\/j.ebiom.2021.103661","volume":"73","author":"M Lewinska","year":"2021","unstructured":"Lewinska M, Santos-Laso A, Arretxe E, Alonso C, Zhuravleva E, Jimenez-Ag\u00fcero R et al (2021) The altered serum lipidome and its diagnostic potential for non-alcoholic fatty liver (NAFL)-associated hepatocellular carcinoma. EBioMedicine 73:103661. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103661","journal-title":"EBioMedicine"},{"key":"11340_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","volume":"149","author":"E Dhamija","year":"2019","unstructured":"Dhamija E, Paul SB, Kedia S (2019) Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern. Indian J Med Res 149:9\u201317. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1456_17","journal-title":"Indian J Med Res"},{"key":"11340_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","volume":"18","author":"J Best","year":"2020","unstructured":"Best J, Bechmann LP, Sowa JP, Sydor S, Dech\u00eane A, Pflanz K et al (2020) GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 18:728-735.e4. https:\/\/doi.org\/10.1016\/j.cgh.2019.11.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11340_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2021.08.028","volume":"76","author":"AG Singal","year":"2022","unstructured":"Singal AG, El-Serag HB (2022) Rational HCC screening approaches for patients with NAFLD. J Hepatol 76:195\u2013201. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.028","journal-title":"J Hepatol"},{"key":"11340_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I et al (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13:91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nat Chem Biol"},{"key":"11340_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-021-00294-7","volume":"16","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li S, Li F, Lv C, Yang QK (2021) High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma. Biol Direct 16:10. https:\/\/doi.org\/10.1186\/s13062-021-00294-7","journal-title":"Biol Direct"},{"key":"11340_CR32","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.asjsur.2021.11.048","volume":"45","author":"XD Huang","year":"2022","unstructured":"Huang XD, Xiao FJ, Guo YT, Sun Y, Zhang YK, Shi XJ (2022) Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis. Asian J Surg 45:2214\u20132223. https:\/\/doi.org\/10.1016\/j.asjsur.2021.11.048","journal-title":"Asian J Surg"},{"key":"11340_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"J Chen","year":"2021","unstructured":"Chen J, Ding C, Chen Y, Hu W, Yu C, Peng C et al (2021) ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett 502:154\u2013165. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.019","journal-title":"Cancer Lett"},{"key":"11340_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105126","volume":"9","author":"H Li","year":"2022","unstructured":"Li H, Song J, He Y, Liu Y, Liu Z, Sun W et al (2022) CRISPR\/Cas9 screens reveal that hexokinase 2 enhances cancer stemness and tumorigenicity by activating the ACSL4-fatty acid \u03b2-oxidation pathway. Adv Sci (Weinh) 9:e2105126. https:\/\/doi.org\/10.1002\/advs.202105126","journal-title":"Adv Sci (Weinh)"},{"key":"11340_CR35","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.7150\/jca.71619","volume":"13","author":"G Shao","year":"2022","unstructured":"Shao G, Qian Y, Lu L, Liu Y, Wu T, Ji G, Xu H (2022) Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer. J Cancer 13:2430\u20132439. https:\/\/doi.org\/10.7150\/jca.71619","journal-title":"J Cancer"},{"key":"11340_CR36","doi-asserted-by":"publisher","first-page":"e06557","DOI":"10.7554\/eLife.06557","volume":"4","author":"X Rong","year":"2015","unstructured":"Rong X, Wang B, Dunham MM, Hedde PN, Wong JS, Gratton E et al (2015) Lpcat3-dependent production of Arachidonoyl phospholipids is a key determinant of triglyceride secretion. eLife 4:e06557. https:\/\/doi.org\/10.7554\/eLife.06557","journal-title":"eLife"},{"issue":"10","key":"11340_CR37","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.21037\/tcr-22-985","volume":"11","author":"P Ke","year":"2022","unstructured":"Ke P, Bao X, Liu C, Zhou B, Huo M, Chen Y et al (2022) LPCAT3 is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis. Transl Cancer Res 11(10):3491\u20133505. https:\/\/doi.org\/10.21037\/tcr-22-985","journal-title":"Transl Cancer Res"},{"key":"11340_CR38","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.2147\/IJGM.S344723","volume":"14","author":"T Lin","year":"2021","unstructured":"Lin T, Zhang E, Lin Z, Peng L (2021) Comprehensive analysis of LPCATs highlights the prognostic and immunological values of LPCAT1\/4 in hepatocellular carcinoma. Int J Gen Med 14:9117\u20139130. https:\/\/doi.org\/10.2147\/IJGM.S344723","journal-title":"Int J Gen Med"},{"key":"11340_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/82_2016_508","volume":"403","author":"H Imai","year":"2017","unstructured":"Imai H, Matsuoka M, Kumagai T, Sakamoto T, Koumura T (2017) Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr Top Microbiol Immunol 403:143\u2013170. https:\/\/doi.org\/10.1007\/82_2016_508","journal-title":"Curr Top Microbiol Immunol"},{"key":"11340_CR40","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.4081\/ejh.2015.2540","volume":"59","author":"E Guerriero","year":"2015","unstructured":"Guerriero E, Capone F, Accardo M, Sorice A, Costantini M, Colonna G et al (2015) GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues. Eur J Histochem 59:2540. https:\/\/doi.org\/10.4081\/ejh.2015.2540","journal-title":"Eur J Histochem"},{"key":"11340_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071826","volume":"14","author":"D Bekric","year":"2022","unstructured":"Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, Neureiter D (2022) Ferroptosis in hepatocellular carcinoma: mechanisms, drug targets and approaches to clinical translation. Cancers (Basel) 14:1826. https:\/\/doi.org\/10.3390\/cancers14071826","journal-title":"Cancers (Basel)"},{"key":"11340_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12192-022-01271-3","volume":"27","author":"J Zhou","year":"2022","unstructured":"Zhou J, Xiao C, Zheng S, Wang Q, Zhu H, Zhang Y et al (2022) MicroRNA-214-3p aggravates ferroptosis by targeting GPX4 in cisplatin-induced acute kidney injury. Cell Stress Chaperones 27:325\u2013336. https:\/\/doi.org\/10.1007\/s12192-022-01271-3","journal-title":"Cell Stress Chaperones"},{"key":"11340_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jot.2024.10.014","volume":"51","author":"R Zuo","year":"2025","unstructured":"Zuo R, Cao B, Kong L, Wang F, Li S, Shan H et al (2025) MiR-370-3p regulate TLR4\/SLC7A11\/GPX4 to alleviate the progression of glucocorticoids-induced osteonecrosis of the femoral head by promoting osteogenesis and suppressing ferroptosis. J Orthop Transl 51:337\u2013358. https:\/\/doi.org\/10.1016\/j.jot.2024.10.014","journal-title":"J Orthop Transl"},{"key":"11340_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/mc.23367","volume":"61","author":"L Liu","year":"2022","unstructured":"Liu L, Yao H, Zhou X, Chen J, Chen G, Shi X (2022) MiR-15a-3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer. Mol Carcinog 61:301\u2013310. https:\/\/doi.org\/10.1002\/mc.23367","journal-title":"Mol Carcinog"},{"key":"11340_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41420-021-00659-x","volume":"7","author":"Y Yang","year":"2021","unstructured":"Yang Y, Lin Z, Han Z, Wu Z, Hua J, Zhong R et al (2021) MiR-539 activates the SAPK\/JNK signaling pathway to promote ferropotosis in colorectal cancer by directly targeting TIPE. Cell Death Discov 7:272. https:\/\/doi.org\/10.1038\/s41420-021-00659-x","journal-title":"Cell Death Discov"},{"key":"11340_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2021.02.077","volume":"549","author":"SH Deng","year":"2021","unstructured":"Deng SH, Wu DM, Li L, Liu T, Zhang T, Li J et al (2021) MiR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Biochem Biophys Res Commun 549:54\u201360. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.077","journal-title":"Biochem Biophys Res Commun"},{"key":"11340_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ar.23954","volume":"302","author":"C Zhang","year":"2019","unstructured":"Zhang C, Wang P, Li Y, Huang C, Ni W, Chen Y et al (2019) Role of microRNAs in the development of hepatocellular carcinoma in nonalcoholic fatty liver disease. Anat Rec Hoboken 302:193\u2013200. https:\/\/doi.org\/10.1002\/ar.23954","journal-title":"Anat Rec Hoboken"},{"key":"11340_CR48","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","volume":"65","author":"H Wu","year":"2016","unstructured":"Wu H, Ng R, Chen X, Steer CJ, Song G (2016) MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway. Gut 65:1850\u20131860. https:\/\/doi.org\/10.1136\/gutjnl-2014-308430","journal-title":"Gut"},{"key":"11340_CR49","doi-asserted-by":"publisher","first-page":"8246","DOI":"10.1038\/s41598-024-58704-5","volume":"14","author":"NA Hussein","year":"2024","unstructured":"Hussein NA, Ebid SA, Ahmad MA, Khedr GE, Saad DM (2024) The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases. Sci Rep 14:8246. https:\/\/doi.org\/10.1038\/s41598-024-58704-5","journal-title":"Sci Rep"},{"key":"11340_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/cpr.12223","volume":"48","author":"Y Li","year":"2015","unstructured":"Li Y, Huang R, Wang L, Hao J, Zhang Q, Ling R, Yun J (2015) MicroRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression. Cell Prolif 48:643\u2013649. https:\/\/doi.org\/10.1111\/cpr.12223","journal-title":"Cell Prolif"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11340-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:02:59Z","timestamp":1767034979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11340-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11340"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11340-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that this research was funded by Mounir Armanious Research Center (MARC). The funding body had no role in the design of the study, data collection, analysis, interpretation, or in writing the manuscript. The authors declare no other competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Faculty of Medicine at Ain Shams University (Ethical Approval Number: FMASU R38\/2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"231"}}